BILI vs. IQV, RDDT, GIB, CPAY, KSPI, AER, GRAB, TRU, TOST, and Z
Should you be buying Bilibili stock or one of its competitors? The main competitors of Bilibili include IQVIA (IQV), Reddit (RDDT), CGI (GIB), Corpay (CPAY), Joint Stock Company Kaspi.kz (KSPI), AerCap (AER), Grab (GRAB), TransUnion (TRU), Toast (TOST), and Zillow Group (Z). These companies are all part of the "business services" industry.
Bilibili vs.
IQVIA (NYSE:IQV) and Bilibili (NASDAQ:BILI) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, dividends and community ranking.
In the previous week, Bilibili had 3 more articles in the media than IQVIA. MarketBeat recorded 36 mentions for Bilibili and 33 mentions for IQVIA. IQVIA's average media sentiment score of 0.93 beat Bilibili's score of 0.52 indicating that IQVIA is being referred to more favorably in the media.
IQVIA has higher revenue and earnings than Bilibili. Bilibili is trading at a lower price-to-earnings ratio than IQVIA, indicating that it is currently the more affordable of the two stocks.
89.6% of IQVIA shares are held by institutional investors. Comparatively, 16.1% of Bilibili shares are held by institutional investors. 1.6% of IQVIA shares are held by insiders. Comparatively, 22.2% of Bilibili shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
IQVIA received 275 more outperform votes than Bilibili when rated by MarketBeat users. Likewise, 68.41% of users gave IQVIA an outperform vote while only 61.83% of users gave Bilibili an outperform vote.
IQVIA currently has a consensus price target of $251.22, indicating a potential upside of 31.57%. Bilibili has a consensus price target of $20.33, indicating a potential downside of 10.92%. Given IQVIA's higher probable upside, research analysts plainly believe IQVIA is more favorable than Bilibili.
IQVIA has a net margin of 8.91% compared to Bilibili's net margin of -10.73%. IQVIA's return on equity of 28.81% beat Bilibili's return on equity.
IQVIA has a beta of 1.48, meaning that its share price is 48% more volatile than the S&P 500. Comparatively, Bilibili has a beta of 0.81, meaning that its share price is 19% less volatile than the S&P 500.
Summary
IQVIA beats Bilibili on 14 of the 19 factors compared between the two stocks.
Get Bilibili News Delivered to You Automatically
Sign up to receive the latest news and ratings for BILI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Bilibili Competitors List
Related Companies and Tools
This page (NASDAQ:BILI) was last updated on 2/21/2025 by MarketBeat.com Staff